Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip A. Low, Sid Gilman

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?'. Together they form a unique fingerprint.